Long-term pulmonary morbidity in survivors of congenital diaphragmatic hernia

Daniel Trachsel1, Hiran Selvadurai, Desmond Bohn

  • 1Division of Respiratory Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Pediatric Pulmonology
|February 11, 2005
PubMed

Insights

Adolescent survivors of congenital diaphragmatic hernia (CDH) exhibit persistent mild to moderate airway obstruction and reduced inspiratory muscle strength. Many patients show significant improvement in lung function after bronchodilator use, indicating potential for targeted therapies.

Area of Science:

  • Pediatric Pulmonology
  • Thoracic Surgery
  • Critical Care Medicine

Background:

  • Congenital diaphragmatic hernia (CDH) is a serious birth defect impacting lung development.
  • Long-term respiratory sequelae in CDH survivors require further investigation.

Purpose of the Study:

  • To evaluate the long-term respiratory outcomes in adolescent survivors of congenital diaphragmatic hernia (CDH).
  • To assess pulmonary function, inspiratory muscle strength, and response to bronchodilators in CDH patients.

Main Methods:

  • A cohort study comparing 26 adolescent CDH survivors with age- and gender-matched controls.
  • Pulmonary function testing including maximum inspiratory/expiratory pressures (MIPS/MEPS) and maximum voluntary ventilation (MVV).
  • Analysis of medical histories and statistical comparison using t-tests and regression.

Main Results:

  • CDH survivors showed significantly reduced forced expiratory volume in one second (FEV(1)), FEF(25-75), MVV, and MIPS compared to controls.
  • Forty-eight percent of CDH patients demonstrated significant FEV(1) improvement post-bronchodilator, versus 4% of controls.
  • Reduced MVV was strongly correlated with reduced FEV(1).

Conclusions:

  • Long-term respiratory outcomes in adolescent CDH survivors are characterized by mild to moderate airway obstruction and diminished inspiratory muscle strength.
  • A high prevalence of bronchodilator responsiveness suggests potential therapeutic targets.
  • Findings emphasize the need for tailored follow-up and perioperative management in CDH patients.

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.